Stryker Endoscopy
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Stryker Endoscopy sits in the upper quartile of US sponsors by registered trial count (#2,914 of 15,742 sponsors by registered trial count).
Stryker Endoscopy: 4 sponsored US clinical trials, 2 recruiting.
Stryker Endoscopy sponsors 4 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting. 0 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hip Injuries, with 1 trials.
Upper-quartile sponsor footprint
Stryker Endoscopy sits in the upper quartile of the sponsor corpus (#2,914 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
4 total, page 1 of 1
SportsPro: Post-Market Clinical Follow Up Study
NCT06320925
InSpace Accelerated Rehabilitation Study
NCT05329584
PROspect Registry :Post Market Clinical Follow-up Study
NCT07631468
SPY Fluorescence Imaging Systems and Indocyanine Green to Determine the Percentage of Successful Critical Anatomy Recognition in Laparoscopic Cholecystectomy Surgeries.
NCT05006950
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
Therapeutic Areas
What is open in the Stryker Endoscopy pipeline
2 recruiting of 4 indexed (50% open).
Phase mix: 0 late (III/IV) vs 1 early (I/II) (early-phase heavy).
Top condition: Hip Injuries (1 trial), 3 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Stryker Endoscopy: open-pipeline peers nationwide
Peers matched on 4 registered trials and 50% open enrollment, not the therapeutic-area sidebar.
Stryker Endoscopy sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 trials (± recruiting share)
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors near 50% open enrollment (± trial volume)
- 1200 Pharma · 50% recruiting · 2 trials
- 1ST Biotherapeutics · 50% recruiting · 2 trials
- 3ive Labs · 50% recruiting · 2 trials
- 7 Hills Pharma · 50% recruiting · 2 trials
Related
What to do with this Stryker Endoscopy page
4 registered trials is a research-attention snapshot, not an endorsement of Stryker Endoscopy or any single study.
- 2 of Stryker Endoscopy's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Hip Injuries is the condition Stryker Endoscopy studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hip Injuries trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Stryker Endoscopy pipeline card: 4 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.